Ethocle Reports has published its latest Market Research Report on Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.

1. Drug ElutingStents (DES) - Medical DevicesPipeline Assessment,2016
Ethocle Reportshaspublished its latest MarketResearch Reporton Drug Eluting Stents(DES) - Medical
DevicesPipeline Assessment,2016. Formulatesignificantcompetitorinformation, analysis,and insights
to improveR&D strategies.Browsemarketdata tablesand figures.
PublishedOn:05-Dec-2016 | Pages: 268
Summary
GlobalData'sMedical Devicessectorreport,“DrugElutingStents(DES) - Medical DevicesPipeline
Assessment,2016" providesanoverview of DrugElutingStents(DES) currentlyinpipeline stage.
The report providescomprehensiveinformationonthe pipeline productswithcomparative analysisof
the productsat variousstagesof development.The reportreviewsmajorplayersinvolvedinthe pipeline
productdevelopment.Italsoprovidesinformationaboutclinical trialsinprogress,whichincludestrial
phase,trial status,trial start and enddates,and,the numberof trialsfor the keyDrug ElutingStents
(DES) pipelineproducts.
Thisreportis preparedusingdatasourcedfromin-house databases,secondaryandprimaryresearchby
GlobalData'steamof industry experts.
*Note:Certainsectionsinthe reportmaybe removedoralteredbasedonthe availabilityandrelevance
of data inrelationtothe equipmenttype.
Click here to find out more about this report?
Scope
- Extensive coverage of the DrugElutingStents(DES) underdevelopment
- The report reviewsdetailsof majorpipeline productswhichincludes,productdescription,licensing
and collaborationdetailsandotherdevelopmental activities

2. - The report reviewsthe majorplayersinvolvedinthe developmentof DrugElutingStents(DES) andlist
all theirpipeline projects
- The coverage of pipeline productsbasedonvariousstagesof developmentrangingfromEarly
DevelopmenttoApproved/Issuedstage
- The report provideskeyclinical trial dataof ongoingtrialsspecifictopipeline products
- Recentdevelopmentsinthe segment/industry
Get Free Sample Report
Click here for Discounts
Reasons to buy
The report enablesyouto -
- Formulate significantcompetitorinformation,analysis,andinsightstoimprove R&Dstrategies
- Identifyemergingplayerswithpotentiallystrongproductportfolioandcreate effective counter-
strategiestogaincompetitiveadvantage
- Identifyandunderstandimportantanddiversetypes of DrugElutingStents(DES) underdevelopment
- Developmarket-entryandmarketexpansionstrategies
- Planmergersandacquisitionseffectivelybyidentifyingmajorplayerswiththe mostpromisingpipeline
- In-depthanalysisof the product’scurrentstage of development,territoryandestimatedlaunchdate
Table of Contents
1.1 Listof Tables8
1.2 Listof Figures17
2 Introduction18
2.1 Drug ElutingStents(DES) Overview18
3 ProductsunderDevelopment19
3.1 Drug ElutingStents(DES) - Pipeline ProductsbyStage of Development19
3.2 Drug ElutingStents(DES) - Pipeline ProductsbyTerritory20

3. 3.3 Drug ElutingStents(DES) - Pipeline ProductsbyRegulatoryPath21
3.4 Drug ElutingStents(DES) - Pipeline ProductsbyEstimatedApproval Date 22
3.5 Drug ElutingStents(DES) - OngoingClinical Trials23
4 Drug ElutingStents(DES) - Pipeline ProductsunderDevelopmentbyCompanies24
4.1 Drug ElutingStents(DES) Companies - Pipeline ProductsbyStage of Development24
4.2 Drug ElutingStents(DES) - Pipeline ProductsbyStage of Development27
5 Drug ElutingStents(DES) CompaniesandProductOverview30
5.1 AachenResonance GmbHCompanyOverview30
5.1.1 AachenResonance GmbHPipeline Products&OngoingClinical TrialsOverview 30
5.2 AbbottVascularInc.CompanyOverview 31
5.2.1 AbbottVascularInc.PipelineProducts&OngoingClinical TrialsOverview 31
5.3 AdcompTechnologiesInc.CompanyOverview 35
5.3.1 AdcompTechnologiesInc.PipelineProducts&OngoingClinicalTrialsOverview35
5.4 AeonBioscience CompanyOverview 36
5.4.1 AeonBioscience Pipeline Products&OngoingClinical TrialsOverview 36
5.5 AlviMedicaMedical TechnologiesInc.CompanyOverview 37
5.5.1 AlviMedicaMedical TechnologiesInc.PipelineProducts& OngoingClinical TrialsOverview 37
5.6 AmaranthMedical Inc CompanyOverview 44
5.6.1 AmaranthMedical Inc Pipeline Products&OngoingClinical TrialsOverview 44
5.7 Arravasc Ltd CompanyOverview46
5.7.1 Arravasc Ltd Pipeline Products&OngoingClinical TrialsOverview 46
5.8 B. Braun MelsungenAGCompanyOverview 47
5.8.1 B. Braun MelsungenAGPipeline Products&OngoingClinical TrialsOverview 47
5.9 BiosensorsInternationalGroupLtdCompanyOverview 48
5.9.1 BiosensorsInternationalGroupLtdPipelineProducts&OngoingClinical TrialsOverview 48

4. 5.10 BiotronikSE& Co KG CompanyOverview56
5.10.1 BiotronikSE & Co KG Pipeline Products&OngoingClinical TrialsOverview 56
5.11 BostonScientificCorpCompanyOverview 72
5.11.1 Boston ScientificCorpPipelineProducts&OngoingClinical TrialsOverview 72
5.12 CardionovumGmbHCompanyOverview 76
5.12.1 CardionovumGmbHPipelineProducts&OngoingClinical TrialsOverview76
5.13 CARDIOREV PTE. LTD CompanyOverview 77
5.13.1 CARDIOREV PTE. LTD Pipeline Products&OngoingClinical TrialsOverview 77
5.14 ColumbiaUniversityCompanyOverview 78
5.14.1 ColumbiaUniversityPipeline Products&OngoingClinical TrialsOverview 78
5.15 ContegoMedical,LLC CompanyOverview79
5.15.1 ContegoMedical,LLC Pipeline Products&OngoingClinical TrialsOverview 79
5.16 CordisCorp CompanyOverview80
5.16.1 CordisCorp Pipeline Products&OngoingClinical TrialsOverview 80
5.17 DISA Vascular(Pty) Ltd.CompanyOverview 85
5.17.1 DISA Vascular(Pty) Ltd.Pipeline Products&OngoingClinical TrialsOverview 85
5.18 DivyaLaboratoriesCompanyOverview 86
5.18.1 DivyaLaboratoriesPipeline Products&OngoingClinical TrialsOverview 86
5.19 ElixirMedical CorpCompanyOverview87
5.19.1 ElixirMedical CorpPipeline Products&OngoingClinical TrialsOverview87
5.20 EnvisionScientificPvt.LtdCompanyOverview 90
5.20.1 EnvisionScientificPvt.LtdPipelineProducts&OngoingClinical TrialsOverview 90
5.21 I.B.S.S.p.A.CompanyOverview92
5.21.1 I.B.S.S.p.A.Pipeline Products&OngoingClinical TrialsOverview 92
5.22 InspireMDInc CompanyOverview93

5. 5.22.1 InspireMDInc Pipeline Products&OngoingClinical TrialsOverview 93
5.23 KanekaCorp CompanyOverview95
5.23.1 KanekaCorp Pipeline Products&OngoingClinical TrialsOverview 95
5.24 Lepu Medical Technology(Beijing) CoLtdCompanyOverview 97
5.24.1 Lepu Medical Technology(Beijing) CoLtdPipeline Products&OngoingClinical TrialsOverview97
5.25 Medinol Ltd CompanyOverview102
5.25.1 Medinol Ltd Pipeline Products&OngoingClinical TrialsOverview 102
5.26 MedlogicsDevice CorpCompanyOverview 108
5.26.1 MedlogicsDevice CorpPipeline Products&OngoingClinical TrialsOverview 108
5.27 Medtronicplc CompanyOverview109
5.27.1 Medtronicplc Pipeline Products&OngoingClinical TrialsOverview 109
5.28 Meril Life SciencesPvtLtdCompanyOverview 117
5.28.1 Meril Life SciencesPvtLtd Pipeline Products&OngoingClinical TrialsOverview 117
5.29 Micell TechnologiesIncCompanyOverview 123
5.29.1 Micell TechnologiesIncPipelineProducts&OngoingClinical TrialsOverview 123
5.30 MicroPort ScientificCorpCompanyOverview 127
5.30.1 MicroPort ScientificCorpPipeline Products&OngoingClinical TrialsOverview 127
5.31 MinvasysCompanyOverview 131
5.31.1 MinvasysPipelineProducts&OngoingClinicalTrialsOverview131
5.32 MIV TherapeuticsIncCompanyOverview 132
5.32.1 MIV TherapeuticsIncPipeline Products&OngoingClinical TrialsOverview 132
5.33 NorthwesternUniversityCompanyOverview 136
5.33.1 NorthwesternUniversityPipeline Products&OngoingClinical TrialsOverview 136
5.34 NuVascularTechnologiesIncCompanyOverview138
5.34.1 NuVascularTechnologiesIncPipeline Products&OngoingClinical TrialsOverview 138

6. 5.35 OrbusNeichCompanyOverview139
5.35.1 OrbusNeichPipeline Products&OngoingClinical TrialsOverview 139
5.36 RelisysMedical DevicesLtdCompanyOverview 146
5.36.1 RelisysMedical DevicesLtdPipeline Products&OngoingClinical TrialsOverview 146
5.37 REVA Medical IncCompanyOverview 148
5.37.1 REVA Medical Inc Pipeline Products&OngoingClinical TrialsOverview 148
5.38 RontisAG CompanyOverview 150
5.38.1 RontisAG PipelineProducts&OngoingClinical TrialsOverview 150
5.39 SinoMedical-DeviceTechnologyCo.,Ltd.CompanyOverview 151
5.39.1 SinoMedical-Device TechnologyCo.,Ltd.PipelineProducts&OngoingClinical TrialsOverview
151
5.40 StentysSA CompanyOverview 155
5.40.1 StentysSA PipelineProducts&OngoingClinical TrialsOverview 155
5.41 Svelte Medical Systems,Inc.CompanyOverview 157
5.41.1 Svelte Medical Systems,Inc.PipelineProducts&OngoingClinical TrialsOverview 157
5.42 TerumoCorp CompanyOverview 161
5.42.1 Terumo CorpPipelineProducts&OngoingClinical TrialsOverview161
5.43 Tryton Medical Inc CompanyOverview 163
5.43.1 Tryton Medical Inc Pipeline Products&OngoingClinical TrialsOverview 163
5.44 Universityof AlabamaatBirminghamCompanyOverview 166
5.44.1 Universityof AlabamaatBirminghamPipelineProducts&OngoingClinical TrialsOverview 166
5.45 Universityof FloridaCompanyOverview168
5.45.1 Universityof FloridaPipeline Products&OngoingClinical TrialsOverview 168
5.46 Universityof Strathclyde CompanyOverview 170
5.46.1 Universityof Strathclyde Pipeline Products&OngoingClinical TrialsOverview 170
5.47 VascularConceptsLtd CompanyOverview 172

7. 5.47.1 VascularConceptsLtd Pipeline Products&OngoingClinical TrialsOverview 172
5.48 ZorionMedical CompanyOverview 175
5.48.1 Zorion Medical PipelineProducts&OngoingClinicalTrialsOverview175
6 Drug ElutingStents(DES)- RecentDevelopments177
6.1 Nov28, 2016: Micell TechnologiesAnnouncesFirstPatientEnrolledInLandmarkRegistrationTrial Of
MiStentIn Japan177
6.2 Nov22, 2016: MedtronicReportsSecondQuarterFinancial Results178
6.3 Nov21, 2016: OrbusNeichIntroducesaNew GenerationCOMBOPlusDual TherapyStentforActive
Healing180
6.4 Nov18, 2016: MicroPort's FiresorbStarsinTCT 2016 181
6.5 Nov18, 2016: MicroPort's FirehawkStarsinTCT 2016 182
6.6 Nov16, 2016: MedtronicReleasesFY16IntegratedPerformanceReport182
6.7 Nov15, 2016: CEVA to workwithMedtronicfor distributionfacilityconstruction183
6.8 Nov14, 2016: InspireMDReportsFinancial Results forthe ThirdQuarterEndedSeptember30, 2016
183
6.9 Nov07, 2016: Medinol receivesapproval fromthe JapanesePMDA tobeginclinical studyonnovel
DES 185
6.10 Nov07, 2016: ARIADReportsThirdQuarter 2016 Financial Results186
6.11 Nov01, 2016: TCT 2016: PhysiciansShare PositiveExperienceswithMagmarisResorbable Scaffold
at Symposium188
6.12 Oct 31, 2016: First Clinical Dataof MedtronicDrug-FilledStentShow PositiveOutcomes189
6.13 Oct 31, 2016: TCT 2016: OrsiroDrug-ElutingStentProvesNon-InferioritytoResoluteIntegrityand
SynergyStents190
6.14 Oct 31, 2016: Positive Five-YearClinical DatafromMicell Technologies'MiStentPresentedatTCT
2016 191
6.15 Oct 31, 2016: Svelte Medical SystemsAnnouncesStartof DIRECT III Post-MarketRegistryStudy192
6.16 Oct 30, 2016: IndependentStudyFindsBiodegradable PolymerStentsProvide NoClinical Benefit
OverResolute IntegrityDES192
6.17 Oct 28, 2016: Tryton Medical EntersIntoStrategicAgreementwithCardinal Health193

8. 6.18 Oct 28, 2016: MicroPort WinsAnnual PMO Awardof PMI (China) 194
6.19 Oct 28, 2016: REVA Medical:QuarterEnded30 September2016 195
6.20 Oct 26, 2016: BostonScientificAnnouncesResultsForThirdQuarter2016 195
6.21 Oct 24, 2016: Svelte Medical SystemsAnnouncesCEMark Certificationof DIRECTRX 197
6.22 Oct 19, 2016: FirehawkReceivesSouthKoreaKGMPCertification198
6.23 Oct 19, 2016: AbbottReportsThird-Quarter2016 Results198
6.24 Oct 19, 2016: ElixirMedical AnnouncesScheduleof ProgramsforTCT 2016 200
6.25 Oct 17, 2016: Tryton Medical AnnouncesClinical SymposiumonTreatmentof ComplexBifurcation
LesionsatTCT 2016 202
6.26 Oct 17, 2016: First FirehawkImplantationinPakistanCompleted203
6.27 Oct 17, 2016: MicroPort ConcludesEnrollmentIn Randomized,Multicenter,EuropeanStudyOf
FirehawkCoronaryStentSystem203
6.28 Oct 10, 2016: ProfessorIanMeredithToJoinBostonScientificAsExecutiveVice PresidentAnd
Global Chief Medical Officer204
6.29 Sep29, 2016: BIOTRONIKBeginsManufacturingHigh-TechProductsinSingapore205
6.30 Sep15, 2016: STENTYS Reports2016 First-Half Results205
6.31 Sep15, 2016: MedtronicNamesMark Ploof SeniorVice Presidentof Global Operationsand
BusinessServices207
6.32 Sep12, 2016: FirehawkReceives RegulatoryApprovalinPakistan207
6.33 Sep07, 2016: InspireMDAppointsThomasKestertoBoardof Directors208
6.34 Sep01, 2016: FirstFirehawkImplantationinEastEurope Completed208
6.35 Aug 30, 2016: BASKET-SAVAGEtrial:Drug-elutingstentsmore benefitinsaphenousveingrafts209
6.36 Aug 30, 2016: MPSC Announces2016 InterimResults209
6.37 Aug 25, 2016: MedtronicReportsFirstQuarterFinancial Results211
6.38 Aug 24, 2016: FirehawkGrantedMarketLaunchin Vietnam213
6.39 Aug 24, 2016: Innovation,Translation,andCooperation:MicroPortAttendsCHC2016 to Present
Firehawk214

9. 6.40 Aug 15, 2016: FirehawkApprovedforMarketLaunchin Argentina215
6.41 Aug 09, 2016: InspireMDReportsFinancial Resultsforthe SecondQuarterEndedJune 30,2016 215
6.42 Jul 29, 2016: REVA Medical:QuarterEnded30 June 2016 217
6.43 Jul 28, 2016: BostonScientificAnnouncesResultsForSecondQuarter2016 218
6.44 Jul 28, 2016: ARIADReportsSecondQuarterand FirstHalf 2016 Financial Results219
6.45 Jul 21, 2016: FirehawkGrantedMarketApproval inIndia221
6.46 Jul 21, 2016: Svelte Medical SystemsRaisesUSD4MillioninVenture Financing222
6.47 Jul 20, 2016: AbbottReportsSecond-Quarter2016 Results222
6.48 Jul 19, 2016: STENTYS EnrollsFirstPatient inLeftMain Clinical Trial 224
6.49 Jul 13, 2016: BostonScientificElectsYoshiakiFujimori toBoardof Directors225
6.50 Jul 12, 2016: STENTYS: 41% Increase inRevenuesinthe SecondQuarterof 2016 225
6.51 Jul 05, 2016: OutcomesfromTryton Medical Pivotal ConfirmatoryStudyPublishedinJACC
CardiovascularInterventions225
6.52 Jul 04, 2016: STENTYS: Appointmentof CardiolovascularDeviceVeteranasNew CEO226
6.53 Jun 30, 2016: NuVasiveAgreestoSettlePatentLitigationWithMedtronic227
6.54 Jun 29, 2016: InspireMDRaisesUSD14.6 MillioninPublicOfferingof PreferredStockandWarrants
227
6.55 Jun 20, 2016: Micell TechnologiesRaisesUSD25.8 MillioninVentureFinancing227
6.56 Jun 17, 2016: ARIADCompletesStrategicReview andAnnounces PlansforGrowth227
6.57 Jun 15, 2016: BIOTRONIKAnnouncesCEMark forMagmaris, the FirstClinicallyProven
Bioresorbable MagnesiumScaffold228
6.58 Jun 08, 2016: STENTYSAnnouncesCEMarking Of ItsLongestXpositionStent229
6.59 Jun 08, 2016: Boston ScientificAnnouncesRestructuringProgramtoSupportLong-TermGrowth
and Innovation229
6.60 Jun 06, 2016: MedtronicOutlinesFutureGrowthVisionatInvestorDay230
6.61 Jun 03, 2016: LepuMedical ReleasesUpdatesof Clinical trial resultsof NeoVasStentinEuroPCR
2016 230

10. 6.62 Jun 03, 2016: LEPUCARE establishedinIndia231
7 Appendix265
7.1 Methodology265
7.2 AboutGlobalData268
7.3 Contact Us 268
7.4 Disclaimer268